Your browser doesn't support javascript.
Viral load of SARS-CoV-2 Omicron is not high despite its high infectivity.
Yuasa, Sonoka; Nakajima, Jun; Takatsuki, Yuna; Takahashi, Yuta; Tani-Sassa, Chihiro; Iwasaki, Yumi; Nagano, Katsutoshi; Sonobe, Kazunari; Yoshimoto, Tomoyo; Nukui, Yoko; Takeuchi, Hiroaki; Tanimoto, Kousuke; Tanaka, Yukie; Kimura, Akinori; Ichimura, Naoya; Tohda, Shuji.
  • Yuasa S; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Nakajima J; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Takatsuki Y; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Takahashi Y; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Tani-Sassa C; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Iwasaki Y; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Nagano K; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Sonobe K; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Yoshimoto T; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Nukui Y; Infection Control and Prevention, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
  • Takeuchi H; Department of Molecular Virology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanimoto K; Genome Laboratory, Medical Research Institute, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tanaka Y; Research Core, Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Kimura A; Department of Molecular Microbiology, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Ichimura N; Institute of Research, Tokyo Medical and Dental University (TMDU), Tokyo, Japan.
  • Tohda S; Clinical Laboratory, Tokyo Medical and Dental University (TMDU) Hospital, Tokyo, Japan.
J Med Virol ; 94(11): 5543-5546, 2022 Nov.
Article in English | MEDLINE | ID: covidwho-1913851
ABSTRACT
Patients infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 has increased worldwide since the beginning of 2022 and the variant has spread more rapidly than the Delta variant, which spread in the summer of 2021. It is important to clarify the cause of the strong transmissibility of the Omicron variant to control its spread. In 694 patients with coronavirus disease 2019, the copy numbers of virus in nasopharyngeal swab-soaked samples and the viral genotypes were examined using quantitative polymerase chain reaction (PCR) and PCR-based melting curve analysis, respectively. Whole-genome sequencing was also performed to verify the viral genotyping data. There was no significant difference (p = 0.052) in the copy numbers between the Delta variant cases (median 1.5 × 105 copies/µl, n = 174) and Omicron variant cases (median 1.2 × 105 copies/µl, n = 328). During this study, Omicron BA.1 cases (median 1.1 ×105 copies/µl, n = 275) began to be replaced by BA.2 cases (median 2.3 × 105 copies/µl, n = 53), and there was no significant difference between the two groups (p = 0.33). Our results suggest that increased infectivity of the Omicron variant and its derivative BA.2 is not caused by higher viral loads but by other factors, such as increased affinity to cell receptors or immune escape.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Variants Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27974

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Randomized controlled trials Topics: Variants Limits: Humans Language: English Journal: J Med Virol Year: 2022 Document Type: Article Affiliation country: Jmv.27974